Natco Pharma Limited Carfilzomib Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Carfilzomib Export Records India — #3 Exporter, 7 Shipments, $31.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Carfilzomib

India Pharmaceutical Trade Intelligence

$1.2M65 Suppliers47 CountriesHS 30049049

ExportsIndia → RUSSIA60.7%India → CHILE7.4%

ImportsIRELAND → India$9.4M CANADA → India$518.8K

#1 Supplier: MSN LABORATORIES

Natco Pharma Limited — Carfilzomib Exporter #3 | $31.8K Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Carfilzomib Exporter Profile

Indian Pharmaceutical Exporter · #3 for Carfilzomib · $31.8K export value · DGFT Verified

Natco Pharma Limited is the #3 Indian exporter of Carfilzomib with $31.8K in export value and 7 verified shipments. Natco Pharma Limited holds a 2.6% market share in Carfilzomib exports across 2 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Carfilzomib Export Profile: Buyers & Destinations

Natco Pharma Limited Carfilzomib export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Carfilzomib?

Country	Value	Shipments	Share
ECUADOR	$53.3K	2	12.8%
RUSSIA	$50.0K	1	12.0%
CHILE	$50.0K	1	12.0%
UNITED ARAB EMIRATES	$48.9K	16

Who Are the Top Buyers of Carfilzomib from India?

Buyer	Country	Value	Orders
ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA	ECUADOR	$53.3K	2
VLADIMIR GASPARYAN	ARMENIA	$23.2K	6
EVEREST BANK LTD	NEPAL	$19.5K	3
RAFTAR MARIME FZE	UNITED ARAB EMIRATES	$19.2K	4
VLADIMIR GASPARYAN APP	ARMENIA	$11.6K	2
SIMONE TAMARA WILLIAMS	JAMAICA	$7.6K	4
LAMAR INTERNATIONAL	SOUTH AFRICA	$6.8K	2
SKIN LINE LOGISTIC	IRAQ	$5.1K	10

India's Carfilzomib is purchased by 105 buyers worldwide. The top buyer is ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA (ECUADOR), followed by VLADIMIR GASPARYAN and EVEREST BANK LTD.

How Does Natco Pharma Limited Compare to Nearest Carfilzomib Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MSN LABORATORIES PRIVATE LIMITED	$90.9K	19	4	$4.8K
2	SARTAJ PHARMA PRIVATE LIMITED	$32.9K	7	3	$4.7K
3	NATCO PHARMA LIMITED ★	$31.8K	7	2	$4.5K
4	3S CORPORATION	$26.4K	8	3	$3.3K
5	RGSK CANADA HEALTHCARE INC.	$25.7K	7	1	$3.7K

Natco Pharma Limited ranks #3 among 65 Indian Carfilzomib exporters. Average shipment value of $4.5K compared to the market average of $4.0K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and SARTAJ PHARMA PRIVATE LIMITED.

Which Indian Ports Ship Carfilzomib Exports?

Port	Shipments	% Share
SAHAR AIR	38	18.7%
SAHAR AIR CARGO ACC (INBOM4)	32	15.8%
DELHI AIR	26	12.8%
HYDERABAD ACC (INHYD4)	19	9.4%
Bombay Air	19	9.4%
DELHI AIR CARGO ACC (INDEL4)	9	4.4%
HYDERABAD AIR	9	4.4%
Bombay Air Cargo	9	4.4%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Carfilzomib Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Carfilzomib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 47+ countries, 105+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Carfilzomib

Carfilzomib

Natco Pharma Limited — Carfilzomib Exporter Profile

Natco Pharma Limited — Carfilzomib Export Profile: Buyers & Destinations

Where Does India Export Carfilzomib?

Who Are the Top Buyers of Carfilzomib from India?

What Is India's Total Carfilzomib Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Carfilzomib Exports?

How Does Natco Pharma Limited Compare to Other Indian Carfilzomib Exporters?

How Does Natco Pharma Limited Compare to Nearest Carfilzomib Exporters?

Which Indian Ports Ship Carfilzomib Exports?

What Other Advanced Oncology Products Does Natco Pharma Limited Export?

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Carfilzomib Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Carfilzomib Export Data from Natco Pharma Limited

Carfilzomib Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source